Effect of interleukin-17 on nitric oxide production and osteoclastic bone resorption: Is there dependency on nuclear factor-kappa B and receptor activator of nuclear factor kappa B (RANK)/RANK ligand signaling?
Rl. Van Bezooijen et al., Effect of interleukin-17 on nitric oxide production and osteoclastic bone resorption: Is there dependency on nuclear factor-kappa B and receptor activator of nuclear factor kappa B (RANK)/RANK ligand signaling?, BONE, 28(4), 2001, pp. 378-386
Interleukin-17 (IL-17) is a proinflammatory cytokine produced exclusively b
y activated memory T cells and has recently been found to stimulate osteocl
astic resorption, Like other proinflammatory cytokines, IL-17 may affect os
teoclastic bone resorption indirectly via osteoblasts, possibly by mechanis
ms previously reported for chondrocytes that respond in very similarly to o
steoblasts, As in chondrocytes, but only in combination with tumor necrosis
factor-alpha (TNF-alpha), IL-17 induced nitric oxide (NO) production in os
teoblastic cells and fetal mouse metatarsals by a nuclear factor-kappaB (NF
-kappaB)-dependent mechanism. This effect was associated with elevated mRNA
levels of the NF-kappaB isoforms RelA and p50, In fetal mouse metatarsals,
IL-17 stimulated osteoclastic bone resorption only in combination with TNF
-alpha, The pathway by which the cytokine combination exerts this effect wa
s examined using inhibitors of NO synthesis and NF-kappaB activation. Altho
ugh both inhibitors used abolished NO production, they did not prevent the
stimulatory effect of the cytokine combination on osteoclastic resorption,
In contrast, the inhibitors slightly increased osteoclastic resorption, sug
gesting a suppressive rather than stimulatory effect of NO on cytokine-indu
ced bone resorption, In addition, we showed that IL-17 + TNF-alpha stimulat
ed osteoclastic resorption independent of NF-kappaB signaling. To further e
xamine the pathway by which osteoclastic resorption was stimulated, we used
osteoprotegerin, a specific inhibitor of the receptor activator of NF-kapp
aB (RANK)/receptor activator of the NF-kappaB ligand (RANKL) pathway. Osteo
protegerin partially inhibited IL-17 + TNF-alpha -stimulated osteoclastic r
esorption only at the high concentration of 1000 ng/mL, whereas it complete
ly blocked parathyroid hormone-related peptide-stimulated resorption at 300
ng/mL. In conclusion, IL-17 stimulated NO production by an NF-kappaB-depen
dent pathway in osteoblastic cells and fetal mouse metatarsals only in comb
ination with TNF-alpha, Neither NO production nor NF-kappaB signaling, and
only partly the RANK/RANKL pathway, were involved in the stimulatory effect
of the cytokine combination on osteoblastic bone resorption in these long
bones, suggesting the existence of other pathways by which osteoclastic res
orption can be stimulated. (Bone 28:378-386; 2001) (C) 2001 by Elsevier Sci
ence Inc. All rights reserved.